📊 Statistics
- Analyst 1 Year Price Target:
$2.74
- Upside/Downside from Analyst Target:
15.63%
- Broker Call:
4
- Dividend Minimum 3 Year Yield:
0.00%
- EPS Growth Range (1Y):
10-25%
- Net Income Growth Range (1Y):
10-25%
- Revenue Growth Range (1Y):
0-10%
-
Upcoming Earnings Date:
-
💰 Dividend History
Current year to date yield:
1.30%
📅 SGX Earnings Announcements for 8A8
8A8 (8A8)
Market: SGX |
Currency: SGD
Address:
📈 8A8 Historical Chart
🧾 Recent Financial Statement Analysis
August 19, 2025
China Medical System Holdings Limited (CMS) Interim Results Analysis: H1 2025 China Medical System Holdings Limited (CMS), a Cayman Islands-incorporated pharmaceutical group, released its unaudited interim results for the six months ended 30 June 2025. The Group is listed on…
🔎 View more in SGX corporate News 🔎 View more in SGX Financial statements
📰 Related News & Research
Showing results matched by any of: 8A8, CMS, CHIH SP, CHINA HOLDINGS, CHINA MEDICAL SYSTEM
November 25, 2025
Broker Name: Maybank Investment Bank Berhad Date of Report: November 25, 2025 Excerpt from Maybank Investment Bank Berhad report. Report Summary Cahya Mata Sarawak (CMS) reported 3Q25 and 9M25 results that underperformed expectations, mainly due to higher-than-expected pre-operating costs in…
November 25, 2025
Broker Name: Maybank Investment Bank Berhad Date of Report: November 25, 2025 Excerpt from Maybank Investment Bank Berhad report. Report Summary: Cahya Mata Sarawak (CMS) reported 3Q25 and 9M25 earnings below expectations due to higher pre-operating costs in its phosphate…
August 19, 2025
China Medical System Holdings Limited (CMS) Interim Results Analysis: H1 2025 China Medical System Holdings Limited (CMS), a Cayman Islands-incorporated pharmaceutical group, released its unaudited interim results for the six months ended 30 June 2025. The Group is listed on…
June 29, 2025
Hong Kong-listed pharmaceutical group China Medical System (CMS) has filed for a secondary listing on the Singapore Exchange (SGX) mainboard, with trading expected to commence in July 2025. The move is part of CMS’s strategy to deepen its footprint in…
